← Open Payments lookup

CELESTE MCGLAMERY: Open Payments

NPI 1326574138 · OLATHE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$941 in 62 payments from 12 companies in 2025. Trend: 2023 $754 · 2024 $754 · 2025 $941

Food & beverage: $941
CompanyPaymentsAmount
ABBVIE INC.35$366
Lilly USA, LLC4$115
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$103
Regeneron Healthcare Solutions, Inc.3$73
Madrigal Pharmaceuticals3$61
PFIZER INC.3$50
Mallinckrodt Hospital Products Inc.2$49
Janssen Biotech, Inc.2$40
Intercept Pharmaceuticals, Inc.2$35
GENZYME CORPORATION1$19

Products named: SKYRIZI, OMVOH, XIFAXAN, DUPIXENT, REZDIFFRA, RINVOQ, TERLIVAZ, LINZESS.

Industry payments across KS — which companies pay providers there.